Shengli Xu

11PUBLICATIONS
29CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Immunogenetics (incl. genetic immunology)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Biological adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 11, 2026
HnRNP A1 and A2B1 enforce Ezh2 mRNA splicing to promote germinal center B cell responses.

|Apr 02, 2025
Minor Splicing Factor RNPC3 Is Essential for the Germinal Center B Cell Response.

Jing Wang, Gui-Xin Ruan, Yuxing Li

|May 15, 2024
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis.

Shi Yong Neo, Le Tong, Joni Chong

|Dec 14, 2023
Spliceosome component PHD finger 5A is essential for early B lymphopoiesis.

Rui Zhang, Daoqin Wang, Gui-Xin Ruan

|Apr 26, 2023
Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer.

Shi Yong Neo, Shengli Xu, Joni Chong

|Mar 30, 2023
The RNA-binding protein hnRNP F is required for the germinal center B cell response.

Hengjun Huang, Yuxing Li, Gaopu Zhang

Pageof 2

Frequent Collaborators

6 joint publications

Xijun Ou

4 joint publications

Hengjun Huang

3 joint publications

Jianxin Huo

3 joint publications

Kong-Peng Lam